Search results for "Dosis"

showing 10 items of 369 documents

2020

The term “amyloid” refers to proteinaceous deposits of peptides that might be generated from larger precursor proteins e.g., by proteolysis. Common to these peptides is a stable cross-β dominated secondary structure which allows self-assembly, leading to insoluble oligomers and lastly to fibrils. These highly ordered protein aggregates have been, for a long time, mainly associated with human neurodegenerative diseases such as Alzheimer’s disease (Amyloid-β peptides). However, they also exert physiological functions such as in release of deposited hormones in human beings. In the light of the rediscovery of our microbial commensals as important companions in health and disease, the fact that…

0303 health sciencesAmyloidmedicine.diagnostic_testMicroorganismAmyloidosisProteolysisOrganic ChemistryNeurodegenerationPharmaceutical ScienceBiologyProtein aggregationmedicine.diseaseAnalytical Chemistry03 medical and health sciences0302 clinical medicineBiochemistryChemistry (miscellaneous)Drug DiscoverymedicineMolecular MedicinePhysical and Theoretical Chemistry030217 neurology & neurosurgery030304 developmental biologyMolecules
researchProduct

Retención a los 6 años en un programa de mantenimiento con metadona y variables relacionadas

2001

Objetivos: conocer la retención en un PMM a los 6 años de una población de heroinóma¬nos de larga evolución y las variables relacionadas con una mayor adherencia.Pacientes, material y métodos: se estudiaron 132 dependientes de opiáceos que comenza¬ron un PMM entre 1991-92. Se les administró un protocolo "ad hoc" recogiendo varia¬bles sociodemográficas y clínicas. Se calculó la retención en tratamiento mediante análisis de supervivencia de Kaplan-Mayer y se buscaron las variables relacionadas con ella.Resultados: el perfil de los estudiados era el de un heroinómano de larga evolución con severos problemas médicos y sociales. La retención ajustada fue del 70,1% a los seis años. Las pérdidas s…

:PSICOLOGÍA::Psicofarmacología [UNESCO]:PSICOLOGÍA [UNESCO]Mantenimiento con metadona Retención Dosis VIH Efectividad.UNESCO::PSICOLOGÍAUNESCO::PSICOLOGÍA::Psicofarmacología
researchProduct

Adicción al deporte: el peligro de la sobredosis de ejercicio

2010

La práctica deportiva forma parte del estilo de vida de los seres humanos postmodernos, pudiendo convertirse en una obsesión cuando su uso es excesivo, continuo, constante e intenso, pudiendo dar lugar a la adicción o dependencia al ejercicio. Actualmente son pocos los estudios e investigaciones hechos al respecto, por ello nuestro objetivo es analizar el estado de la cuestión, sus características psicológicas y psicopatológicas, y elaborar un cuestionario que permita evaluar la adicción al ejercicio, así como establecer su fiabilidad y validez para su detección y manejo clínico. Tras la elaboración del cuestionario, SAS, hemos pretendido observar cómo se manifiesta la adicción a nivel físi…

:PSICOLOGÍA::Psicofarmacología [UNESCO]:PSICOLOGÍA [UNESCO]UNESCO::PSICOLOGÍASobredosis dependencia adicción ejercicio.UNESCO::PSICOLOGÍA::Psicofarmacología
researchProduct

Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations.

2010

Hofer D, Paul K, Fantur K, Beck M, Roubergue A, Vellodi A, Poorthuis BJ, Michelakakis H, Plecko B, Paschke E. Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations. GM1 gangliosidosis manifests with progressive psychomotor deterioration and dysostosis of infantile, juvenile, or adult onset, caused by alterations in the structural gene coding for lysosomal acid s-galactosidase (GLB1). In addition, allelic variants of this gene can result in Morquio B disease (MBD), a phenotype with dysostosis multiplex and entire lack of neurologic involvement. More than 100 sequence alterations in the GLB1 gene have been identified so far, but only few could be proven to …

AdolescentGenotypeNonsense mutationBlotting WesternDNA Mutational AnalysisBiologymedicine.disease_causeCell LineGenotypeChlorocebus aethiopsGeneticsmedicineMissense mutationAnimalsHumansAlleleChildGenetics (clinical)AllelesGeneticsMutationGangliosidosis GM1DysostosisInfantmedicine.diseasebeta-GalactosidasePhenotypePhenotypeGLB1Child PreschoolCOS CellsMutationClinical genetics
researchProduct

Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis

1999

Nucleoside analogue-induced lactic acidosis is an often fatal condition in patients with HIV. There is only one report of successful treatment with riboflavin. We describe a 30-year-old female with AIDS and nucleoside analogue-induced lactic acidosis that exacerbated shortly after introducing total parenteral nutrition and reversed within hours after the addition of thiamine. Successful treatment of nucleoside analogue-induced lactic acidosis with a high dose of thiamine supports the hypothesis that vitamin deficiency is an important cofactor in the development of this rare and unpredictable condition in patients with HIV. We suggest that high dose B-vitamins should be given to any patient …

AdultAnti-HIV AgentsPharmacologymedicineHumansThiamineAcidosisAcquired Immunodeficiency SyndromeNucleoside analoguebusiness.industryfood and beveragesMetabolic acidosismedicine.diseaseDidanosineStavudineB vitaminsAnesthesiology and Pain MedicineBiochemistryLactic acidosisAcidosis LacticFemaleParenteral Nutrition TotalThiaminemedicine.symptombusinessSevere lactic acidosisNucleosidemedicine.drugEuropean Journal of Anaesthesiology
researchProduct

Mutational analysis of 105 mucopolysaccharidosis type VI patients

2007

Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome) is a lysosomal storage disorder caused by mutations in the N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ARSB) gene. ARSB is a lysosomal enzyme involved in the degradation of the glycosaminoglycans (GAG) dermatan and chondroitin sulfate. ARSB mutations reduce enzyme function and GAG degradation, causing lysosomal storage and urinary excretion of these partially degraded substrates. Disease onset and rate of progression is variable, producing a spectrum of clinical presentation. In this study, 105 MPS VI patients—representing about 10% of the world MPS VI population—were studied for molecular genetic and biochemical parame…

AdultArylsulfatase BAdolescentN-Acetylgalactosamine-4-SulfataseMPS VIDNA Mutational AnalysisNonsense mutationMucopolysaccharidosis type VIBiologyPolymorphism Single NucleotideGenetic HeterogeneityAge DistributionGene FrequencyGenotypeGeneticsmedicineHumansMissense mutationGenetic TestingChildCells CulturedGenetics (clinical)mucopolysaccharidosis type VIGlycosaminoglycansGeneticsMucopolysaccharidosis VIGenetic heterogeneityMucopolysaccharidosis VIMiddle Agedmedicine.diseasearylsulfatase BMaroteaux–Lamy syndromeDisease ProgressionARSBMaroteaux-LamyHuman Mutation
researchProduct

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Der…

2021

Abstract Aim Immune checkpoint inhibition (ICI) triggers immune-related adverse events (irAEs). The relevance of lipase elevation remains unclear. Patients and methods Skin cancer patients with newly detected serum lipase elevation (at least twofold upper normal limit) or newly diagnosed type I diabetes mellitus upon ICI therapy were retrospectively collected at 14 German skin cancer centres. Results We identified 68 patients with lipase elevation occurring after a median time of 19 (range 1–181) weeks on ICI, 15 (22%) thereof had symptoms consistent with pancreatitis. Forty-seven patients (73%) had other irAE, mainly colitis. Discontinuation (n = 24, 35%) or interruption (n = 26, 38%) of I…

AdultBlood GlucoseMale0301 basic medicineCancer Researchmedicine.medical_specialtySkin NeoplasmsTime FactorsMedizinGastroenterologyThyroiditisYoung Adult03 medical and health sciences0302 clinical medicinePredictive Value of TestsGermanyInternal medicineDiabetes mellitusmedicineHumansLipaseAdverse effectImmune Checkpoint InhibitorsMelanomaAgedRetrospective StudiesAged 80 and overType 1 diabetesbiologybusiness.industryDiabetes; Diabetes mellitus; Immune checkpoint inhibitors; Immune-related adverse events; Ipilimumab; Lipase; Nivolumab; Pancreatitis; PD-1 inhibitor; Pembrolizumab; Adult; Aged; Aged 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus Type 1; Exocrine Pancreatic Insufficiency; Female; Germany; Humans; Immune Checkpoint Inhibitors; Lipase; Male; Melanoma; Middle Aged; Pancreatitis; Predictive Value of Tests; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Up-Regulation; Young AdultLipaseMiddle Agedmedicine.diseaseUp-RegulationKetoacidosisDiabetes Mellitus Type 1Treatment Outcome030104 developmental biologyPancreatitisOncology030220 oncology & carcinogenesisbiology.proteinPancreatitisExocrine Pancreatic InsufficiencyFemaleSkin cancerbusinessBiomarkersEuropean Journal of Cancer
researchProduct

Effects of muscular exercise on erythrocyte adenosine triphosphate concentration in patients with insulin-dependent diabetes mellitus.

1987

Type I diabetes mellitus represents a metabolic disorder in which intracellular glycolytic pathway is inhibited by insulin deficiency, with the subsequent decreased availability of energetic substrates such as ATP. Some aspects of the energetic metabolism in response to an intensive demand (muscular exercise) were investigated, in a group of 10 ketotic diabetic patients, by measuring erythrocyte adenosine triphosphate (ATP) and blood glucose, free fatty acids (FFA) and lactate levels. In the diabetic subjects, in comparison with normal subjects, the decreased levels of erythrocyte ATP at rest did not increase after exercise, while the increased levels of FFA at rest did not diminish after e…

AdultBlood GlucoseMalemedicine.medical_specialtyContraction (grammar)ErythrocytesClinical BiochemistryPhysical ExertionFatty Acids NonesterifiedDiabetic Ketoacidosischemistry.chemical_compoundAdenosine TriphosphateInternal medicinemedicineHumansGlycolysisIn patientHematologyChemistryMusclesMetabolic disorderMetabolismmedicine.diseaseEndocrinologyDiabetes Mellitus Type 1LactatesFemaleEnergy MetabolismAdenosine triphosphateIntracellularLa Ricerca in clinica e in laboratorio
researchProduct

Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries

2015

To assess the diagnostic value of cardiac MRI (CMR) in patients with acute chest pain, elevated cardiac enzymes and a negative coronary angiogram.This study included a total of 125 patients treated in the chest pain unit during a 39-month period. Each included patient underwent MRI within a median of 3 days after cardiac catheterization. The MRI protocol comprised cine, oedema-sensitive and late gadolinium-enhancement imaging. The standard of reference was a consensus diagnosis based on clinical follow-up and the synopsis of all clinical, laboratory and imaging data.MRI revealed a multitude of diagnoses, including ischaemic cardiomyopathy (CM), dilated CM, myocarditis, Takotsubo CM, hyperte…

AdultGadolinium DTPAMalemedicine.medical_specialtyCardiac CatheterizationChest PainMyocarditismedicine.medical_treatmentContrast MediaMagnetic Resonance Imaging CineChest painCoronary AngiographyRisk AssessmentPredictive Value of TestsRisk FactorsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingMedical diagnosisCardiac catheterizationAgedAged 80 and overFull Paperbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseHypertensive heart diseaseCoronary arteriesmedicine.anatomical_structureCardiac amyloidosisCardiovascular DiseasesPredictive value of testscardiovascular systemCardiologyFemaleRadiologymedicine.symptombusinessBiomarkers
researchProduct

Lung Compartmentalization of Increased TNF Releasing Ability by Mononuclear Phagocytes in Pulmonary Sarcoidosis

1989

The TNF is a monokine with cytotoxic and tumor-necrosing activities; in addition, TNF may play a role in inflammatory processes. The present study evaluates spontaneous and LPS-mediated release of TNF by AMs and autologous peripheral BMs of normal subjects and patients with pulmonary sarcoidosis. A recently developed cytotoxicity assay, specific for detection of TNF activity, was applied. This study demonstrates that (1) unstimulated mononuclear phagocytes released low levels of TNF with no differences between groups; (2) when effector cells were stimulated with LPS, AMs from patients with active pulmonary sarcoidosis released more TNF than AMs recovered from normal subjects and from patien…

AdultLung DiseasesMalePulmonary and Respiratory MedicineSarcoidosisCritical Care and Intensive Care MedicinePathogenesisHumansMedicineMacrophageLungLungTumor Necrosis Factor-alphabusiness.industryMacrophagesRespiratory diseaseMononuclear phagocyte systemCytotoxicity Tests Immunologicmedicine.diseasePulmonary AlveoliMonokinemedicine.anatomical_structureImmunologyLeukocytes MononuclearFemaleTumor necrosis factor alphaSarcoidosisCardiology and Cardiovascular MedicinebusinessBronchoalveolar Lavage FluidChest
researchProduct